Hannah Deresiewicz
Investor Relations Contact at FORTY SEVEN, INC.
Hannah Deresiewicz active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FORTY SEVEN, INC. | Investor Relations Contact | - | - |
| KALA BIO, INC. | Investor Relations Contact | - | - |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/06/2013 | - |
Career history of Hannah Deresiewicz
Statistics
International
| United States | 4 |
Operational
| Investor Relations Contact | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |
- Stock Market
- Insiders
- Hannah Deresiewicz
- Experience
